vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and ZoomInfo Technologies Inc. (GTM). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $319.1M, roughly 1.2× ZoomInfo Technologies Inc.). ZoomInfo Technologies Inc. runs the higher net margin — 10.9% vs 5.3%, a 5.6% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

ZoomInfo Technologies Inc. is a registered data broker in the United States. The company collects and sells personal data, both public and private, through various means of data and web scraping. Information about business entities like companies and departments are also collected and offered. These personal information are available for sale, where other businesses can use the collected data for targeted marketing.

GRDN vs GTM — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.2× larger
GRDN
$397.6M
$319.1M
GTM
Higher net margin
GTM
GTM
5.6% more per $
GTM
10.9%
5.3%
GRDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRDN
GRDN
GTM
GTM
Revenue
$397.6M
$319.1M
Net Profit
$20.9M
$34.7M
Gross Margin
21.5%
84.0%
Operating Margin
7.7%
17.0%
Net Margin
5.3%
10.9%
Revenue YoY
3.2%
Net Profit YoY
137.7%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
GTM
GTM
Q4 25
$397.6M
$319.1M
Q3 25
$377.4M
$318.0M
Q2 25
$344.3M
$306.7M
Q1 25
$329.3M
$305.7M
Q4 24
$309.1M
Q3 24
$314.4M
$303.6M
Q2 24
$291.5M
Q1 24
$310.1M
Net Profit
GRDN
GRDN
GTM
GTM
Q4 25
$20.9M
$34.7M
Q3 25
$9.8M
$38.7M
Q2 25
$9.0M
$24.0M
Q1 25
$9.4M
$26.8M
Q4 24
$14.6M
Q3 24
$-122.0M
$23.8M
Q2 24
$-24.4M
Q1 24
$15.1M
Gross Margin
GRDN
GRDN
GTM
GTM
Q4 25
21.5%
84.0%
Q3 25
19.8%
83.7%
Q2 25
19.8%
83.9%
Q1 25
19.5%
84.5%
Q4 24
82.8%
Q3 24
19.4%
84.4%
Q2 24
84.3%
Q1 24
86.0%
Operating Margin
GRDN
GRDN
GTM
GTM
Q4 25
7.7%
17.0%
Q3 25
4.3%
21.2%
Q2 25
3.7%
17.5%
Q1 25
3.9%
16.5%
Q4 24
10.0%
Q3 24
-33.3%
14.3%
Q2 24
-6.9%
Q1 24
13.9%
Net Margin
GRDN
GRDN
GTM
GTM
Q4 25
5.3%
10.9%
Q3 25
2.6%
12.2%
Q2 25
2.6%
7.8%
Q1 25
2.9%
8.8%
Q4 24
4.7%
Q3 24
-38.8%
7.8%
Q2 24
-8.4%
Q1 24
4.9%
EPS (diluted)
GRDN
GRDN
GTM
GTM
Q4 25
$0.11
Q3 25
$0.12
Q2 25
$0.07
Q1 25
$0.08
Q4 24
$0.04
Q3 24
$0.07
Q2 24
$-0.07
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
GTM
GTM
Cash + ST InvestmentsLiquidity on hand
$65.6M
$179.9M
Total DebtLower is stronger
$0
$1.3B
Stockholders' EquityBook value
$217.9M
$1.5B
Total Assets
$412.7M
$6.4B
Debt / EquityLower = less leverage
0.00×
0.88×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
GTM
GTM
Q4 25
$65.6M
$179.9M
Q3 25
$36.5M
$135.0M
Q2 25
$18.8M
$176.9M
Q1 25
$14.0M
$140.5M
Q4 24
$139.9M
Q3 24
$37.2M
$147.7M
Q2 24
$399.3M
Q1 24
$440.2M
Total Debt
GRDN
GRDN
GTM
GTM
Q4 25
$0
$1.3B
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$34.3M
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
GRDN
GRDN
GTM
GTM
Q4 25
$217.9M
$1.5B
Q3 25
$195.5M
$1.5B
Q2 25
$179.7M
$1.6B
Q1 25
$163.2M
$1.6B
Q4 24
$1.7B
Q3 24
$133.9M
$1.7B
Q2 24
$1.9B
Q1 24
$2.0B
Total Assets
GRDN
GRDN
GTM
GTM
Q4 25
$412.7M
$6.4B
Q3 25
$390.0M
$6.4B
Q2 25
$356.3M
$6.5B
Q1 25
$334.0M
$6.4B
Q4 24
$6.5B
Q3 24
$348.0M
$6.4B
Q2 24
$6.7B
Q1 24
$6.8B
Debt / Equity
GRDN
GRDN
GTM
GTM
Q4 25
0.00×
0.88×
Q3 25
0.87×
Q2 25
0.85×
Q1 25
0.75×
Q4 24
0.72×
Q3 24
0.26×
0.74×
Q2 24
0.66×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
GTM
GTM
Operating Cash FlowLast quarter
$34.6M
$143.5M
Free Cash FlowOCF − Capex
$127.1M
FCF MarginFCF / Revenue
39.8%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
1.65×
4.14×
TTM Free Cash FlowTrailing 4 quarters
$389.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
GTM
GTM
Q4 25
$34.6M
$143.5M
Q3 25
$28.2M
$93.8M
Q2 25
$19.9M
$108.9M
Q1 25
$17.6M
$119.2M
Q4 24
$109.0M
Q3 24
$18.2M
Q2 24
$126.3M
Q1 24
$115.9M
Free Cash Flow
GRDN
GRDN
GTM
GTM
Q4 25
$127.1M
Q3 25
$24.2M
$70.9M
Q2 25
$86.9M
Q1 25
$104.4M
Q4 24
$85.6M
Q3 24
$600.0K
Q2 24
$115.2M
Q1 24
$103.1M
FCF Margin
GRDN
GRDN
GTM
GTM
Q4 25
39.8%
Q3 25
6.4%
22.3%
Q2 25
28.3%
Q1 25
34.2%
Q4 24
27.7%
Q3 24
0.2%
Q2 24
39.5%
Q1 24
33.2%
Capex Intensity
GRDN
GRDN
GTM
GTM
Q4 25
5.1%
Q3 25
1.1%
7.2%
Q2 25
7.2%
Q1 25
4.8%
Q4 24
7.6%
Q3 24
5.8%
Q2 24
3.8%
Q1 24
4.1%
Cash Conversion
GRDN
GRDN
GTM
GTM
Q4 25
1.65×
4.14×
Q3 25
2.87×
2.42×
Q2 25
2.21×
4.54×
Q1 25
1.86×
4.45×
Q4 24
7.47×
Q3 24
0.76×
Q2 24
Q1 24
7.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons